Real-time Quantitative Polymerase Chain Reaction for Dynamic Monitoring of Minimal Residual Disease in Acute Promyelocytic Leukemia after Treatment

NIE Yu,LIU Xin,SUN Zi-min

DOI: https://doi.org/10.3969/j.issn.1671-2587.2012.03.003

2012-01-01

Abstract:Objective To set up a real-time quantitative PCR approach for detection and quantification for PML/RARa transcripts in APL patients,and detect minimal residual disease(MRD) in APL and evaluate the significance of MRD detection.Method Application of real-time quantitative PCR in bone marrow specimens for analysis of 96 patients with APL,detection of PML/RARa fusion gene transcription.Results Application of rank-sum test on the real-time PCR and nested PCR sensitivity analysis,the results showed statistically significant(P<0.05).Prompt application of real-time quantitative PCR detection of PML/RARa fusion gene transcript levels,the sensitivity was higher than the traditional nested PCR.And real-time quantitative PCR could provide a specific value,easy to describe the level changes of patients with PML/RARa fusion gene copy number.The newly diagnosed was high and rapidly decreased after effective treatment,reappeared after recarrence,suggesting that if the patients in complete remission(CR) with PML / RARa fusion gene copy number on the rise,the probability of relapse increased.Conclusion Real-time quantitative PCR is reliable and has important clinical value,it can be used to detect the MRD,monitor the treatment outcome,predict the disease recurrence and give early intervention.